30
Participants
Start Date
December 12, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
mitoxantrone liposome 16 and azacitidine
The mitoxantrone liposome will be intravenous infused at a dose of 16mg/m\^2 on day1 , combined with subcutaneous injection of azacitidine at a dose of 75 mg/m\^2 on days 1-7, with each cycle lasting 4 weeks (28 days).
mitoxantrone liposome 18 and azacitidine
The mitoxantrone liposome will be intravenous infused at a dose of 18mg/m\^2 on day1 , combined with subcutaneous injection of azacitidine at a dose of 75 mg/m\^2 on days 1-7, with each cycle lasting 4 weeks (28 days).
mitoxantrone liposome 20 and azacitidine
The mitoxantrone liposome will be intravenous infused at a dose of 20mg/m\^2 on day1 , combined with subcutaneous injection of azacitidine at a dose of 75 mg/m\^2 on days 1-7, with each cycle lasting 4 weeks (28 days).
RECRUITING
Hubei Cancer Hospital, Wuhan
Collaborators (1)
Beijing Xisike Clinical Oncology Research Foundation
UNKNOWN
CSPC Pharmaceutical Group
UNKNOWN
Huijing Wu
OTHER